National Bank Of Canada Horizon Therapeutics Public LTD CO Transaction History

National Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$98.98 - $115.74 $65.7 Million - $76.8 Million	663,542 Added 302.93%	882,584 $102 Million
Q2 2023 Jul 26, 2023	BUY	$96.34 - $112.38 $19.3 Million - $22.5 Million	199,868 Added 1042.39%	219,042 $22.5 Million
Q1 2023 Apr 12, 2023	SELL	$107.32 - $113.5 $2.29 Million - $2.43 Million	-21,371 Reduced 52.71%	19,174 $2.09 Million
Q4 2022 Jan 24, 2023	SELL	$62.39 - $113.8 $1.68 Million - $3.06 Million	-26,869 Reduced 39.86%	40,545 $0
Q3 2022 Oct 13, 2022	SELL	$58.92 - $84.67 $1.83 Million - $2.63 Million	-31,053 Reduced 31.54%	67,414 $4.23 Million

Q2 2022 Jul 28, 2022	BUY	$79.4 - $116.36 $4.65 Million - $6.82 Million	58,604 Added 147.01%	98,467 $7.89 Million
Q1 2022 May 05, 2022	BUY	$86.42 - $109.81 $2.61 Million - $3.32 Million	30,255 Added 314.89%	39,863 $4.59 Million
Q4 2021 Jan 24, 2022	BUY	$98.56 - $119.91 $946,964 - $1.15 Million	9,608 New	9,608 $1.02 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.